Alvotech
is an Iceland-based biopharmaceutical company that researches and develops biosimilars for the treatment of cancer, autoimmune and inflammatory diseases... Read moreAlvotech
is an Iceland-based biopharmaceutical company that researches and develops biosimilars for the treatment of cancer, autoimmune and inflammatory diseases... Read more
News
Leadership Change
Mar 27, 2025
GlobeNewswire
Balaji V. Prasad joined Alvotech as Chief Strategy Officer
Acquisition
Mar 21, 2025
Medthority
Alvotech acquired Xbrane Biopharma AB’s R&D Operations for $27M
Regulatory
Mar 21, 2025
Drug Store News
FDA accepts BLA submission from Dr. Reddy's, Alvotech for proposed Prolia, Xgeva biosimilars
Conference Presentation
Nov 07, 2024
GlobeNewswire
Alvotech Attending Citi's Global Healthcare Conference on December 4, 2024, and Evercore's HealthCONx Conference on December 5, 2024
Funding
Jun 07, 2024
MarketScreener
Alvotech received $965M in Post-IPO Debt Funding
Alvotech Competitors
1
2
3
4
5
6
7
8
9
10